Skip to main navigation Skip to search Skip to main content

Circulating immune complexes and complement-fixing antibodies in patients with varicella-zoster infection. Relationship to début of the disease

H Nielsen, P Olholm, U Feldt-Rasmussen, A Godtfredsen, S E Svehag

6 Citations (Scopus)

Abstract

Serum samples from 32 varicella-zoster (VZ)-infected patients were examined for circulating immune complexes (IC) within 1 1/2 week after début of the skin rash as well as during the following 5 weeks. Three test systems were used: a complement consumption (CC) assay, a C1q solid phase (CU1-SP) assay and a polyclonal rheumatoid factor-binding (pRF-I) assay. The CC and pRF-I assays were the most effective in detecting large IgG aggregates of IC, while aggregates of intermediate and small size were more easily demonstrated in the C1q-SP assay. IC were demonstrated in at least 2 assays simultaneously in 16 patients. Four of these patients were IC-positive in both observation periods, while 11 converted to IC-positive in the second observation interval. In 3 patients circulating IC were demonstrable as late as 8--10 weeks after the appearance of the skin rash. Maximal levels of complement-fixing antibodies to VZ antigens were observed 2 to 5 weeks after the appearance of the rash.

Original languageEnglish
JournalScandinavian Journal of Infectious Diseases
Volume12
Issue number1
Pages (from-to)21-6
Number of pages6
ISSN0036-5548
DOIs
Publication statusPublished - 1980
Externally publishedYes

Keywords

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral/analysis
  • Antigen-Antibody Complex
  • Antigens, Viral
  • Chickenpox/immunology
  • Chromatography, Gel
  • Complement Fixation Tests
  • Complement System Proteins/immunology
  • Female
  • Herpesvirus 3, Human/immunology
  • Humans
  • Immunoglobulin G/analysis
  • Male
  • Middle Aged

Fingerprint

Dive into the research topics of 'Circulating immune complexes and complement-fixing antibodies in patients with varicella-zoster infection. Relationship to début of the disease'. Together they form a unique fingerprint.

Cite this